Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 216.05 Million | 319.23 Million | 184.26 Million | 99.09 Million | 128.27 Million | 148.52 Million |
| Net Income | 57 Million | 48 Million | 67.96 Million | -353.47 Million | 80.56 Million | 98.44 Million |
| Depreciation & Amortization | 93.6 Million | 96.43 Million | 66.1 Million | 52.87 Million | 55.19 Million | 47.61 Million |
| Deferred income taxes | 7.08 Million | -2.14 Million | 4.82 Million | -21.75 Million | -12.33 Million | -761.14 Thousand |
| Stock-based compensation | - | 2.14 Million | -4.82 Million | 21.75 Million | 12.33 Million | - |
| Change in working capital | 18.62 Million | 135.16 Million | 64.28 Million | 47.34 Million | -100.98 Million | -23.29 Million |
| Other non-cash items | 208.31 Million | 39.62 Million | -14.08 Million | 352.34 Million | 93.49 Million | 25.76 Million |
| Investing Cash Flow | -30.4 Million | -24.47 Million | -85.57 Million | -94.07 Million | -74.37 Million | -119.11 Million |
| Investments in PPE | -24.51 Million | -26.64 Million | -85.96 Million | -96.3 Million | -76.96 Million | -110.24 Million |
| Acquisitions | 14.1 Million | 167.06 Thousand | 121.83 Thousand | 75.75 Thousand | 24.34 Thousand | 972.65 Thousand |
| Investment purchases | -20 Million | -167.05 Thousand | -3.1 Million | -75.75 Thousand | -960 Thousand | -900 Thousand |
| Sales/Maturities of investments | 463.14 Thousand | 2 Million | 3.4 Million | 2.15 Million | 4.51 Million | 859.3 Thousand |
| Other Investing Activities | -15.23 Million | 167.06 Thousand | -37.48 Thousand | 75.75 Thousand | -996.66 Thousand | -9.79 Million |
| Financing Cash Flow | -125.92 Million | -133.93 Million | -86.29 Million | -119.71 Million | 336.33 Million | -107.88 Million |
| Debt repayment | -45.98 Million | -41.03 Million | -37.24 Million | -135.5 Million | -30 Million | -128.6 Million |
| Dividends payments | -53.53 Million | -53.45 Million | -3.96 Million | -5.82 Million | -4.41 Million | -22.03 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.36 Million | -23.92 Million | -45.07 Million | 21.6 Million | 370.75 Million | 42.75 Million |
| Accounts receivables | 100.94 Million | -25.11 Million | -231.76 Million | 148.8 Million | -172.02 Million | -33.26 Million |
| Accounts payables | -59.46 Million | 189.05 Million | 294.47 Million | -40.58 Million | 69.21 Million | -20.93 Million |
| Inventory | -22.84 Million | -26.63 Million | -3.24 Million | -39.11 Million | 14.15 Million | 31.66 Million |
| Other working capital | -52.37 Million | -2.14 Million | 4.82 Million | -21.75 Million | -12.33 Million | -54.96 Million |
| Cash at beginning of period | 656.49 Million | 493.74 Million | 481.35 Million | 596.05 Million | 205.81 Million | 284.28 Million |
| Cash at end of period | 715.27 Million | 654.56 Million | 493.74 Million | 481.35 Million | 596.05 Million | 205.81 Million |
| Capital Expenditure | -24.51 Million | -26.64 Million | -85.96 Million | -96.3 Million | -76.96 Million | -110.24 Million |
| Effect of forex changes on cash | 56.85 | 246.11 | -62.35 | -188.60 | 48.78 | 137.04 |
| Net cash flow / Change in cash | 58.78 Million | 160.82 Million | 12.38 Million | -114.7 Million | 390.23 Million | -78.47 Million |
| Free Cash Flow | 191.54 Million | 292.59 Million | 98.3 Million | 2.79 Million | 51.31 Million | 38.28 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.51 Million | 13.89 Million | 23.94 Million | 57 Million | -8.94 Million | 31.21 Million |
| Depreciation & Amortization | - | 27.17 Million | 27.17 Million | 93.6 Million | 23.42 Million | -45.52 Million |
| Deferred income taxes | 1.11 Million | - | - | 7.08 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 110.07 Million | - | 18.62 Million | 78.09 Million | -144.73 Million |
| Other non-cash items | 35.49 Million | 93.39 Million | 18.86 Million | 208.31 Million | 82.92 Million | 182.18 Million |
| Investing Cash Flow | -10.09 Million | -3.51 Million | -2.24 Million | -30.4 Million | 361.77 Thousand | -3.27 Million |
| Investments in PPE | -10.89 Million | -3.52 Million | -2.25 Million | -24.51 Million | -13.6 Million | -3.28 Million |
| Acquisitions | 8560.00 | 11.7 Thousand | 2150.00 | 14.1 Million | 13.96 Million | -2.99 Million |
| Investment purchases | - | - | - | -20 Million | -20 Million | - |
| Sales/Maturities of investments | 797.13 Thousand | - | - | 463.14 Thousand | - | - |
| Other Investing Activities | - | 11.7 Thousand | 2150.00 | -15.23 Million | 20 Million | 3 Million |
| Financing Cash Flow | 42.03 Million | -68.88 Million | 1.09 Million | -125.92 Million | -43.14 Million | -28.96 Million |
| Debt repayment | -3 Million | -9.3 Million | -8.01 Million | -45.98 Million | -33.82 Million | -2 Million |
| Dividends payments | - | -54.19 Million | -2.79 Million | -53.53 Million | -53.53 Million | -29.64 Million |
| Common Stock Repurchased | - | - | - | - | -3 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 45.03 Million | -5.38 Million | -6.91 Million | -13.36 Million | 57.24 Million | 2.67 Million |
| Accounts receivables | - | 84.79 Million | - | 100.94 Million | 100.94 Million | -151.19 Million |
| Accounts payables | - | - | - | -59.46 Million | - | - |
| Inventory | - | 25.28 Million | - | -22.84 Million | -22.84 Million | 6.46 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 763.65 Million | 755.93 Million | 715.27 Million | 656.49 Million | 708.13 Million | 715.61 Million |
| Cash at end of period | 853.54 Million | 763.65 Million | 756.92 Million | 715.27 Million | 715.27 Million | 706.51 Million |
| Capital Expenditure | -10.89 Million | -3.52 Million | -2.25 Million | -24.51 Million | -13.6 Million | -3.28 Million |
| Effect of forex changes on cash | - | 823.00 | - | 56.85 | 56.00 | 0.40 |
| Net cash flow / Change in cash | 89.88 Million | 7.71 Million | 41.65 Million | 58.78 Million | 7.13 Million | -9.09 Million |
| Free Cash Flow | 47.22 Million | 76.58 Million | 40.55 Million | 191.54 Million | 36.94 Million | 19.86 Million |
HARRMALAYA
CLBTW
AKSI
EPI-A
TTML
NMR